POS0520 Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: Results from a randomized, controlled trial
S. Asai(Nagoya University Hospital), Shiro Imagama(Nagoya University), Hiroki Ishikawa(Institute for Rheumatic Diseases (Japan)), Hiroyasu Shimada(Kagawa University), Toyohiro Kato, Tomonori Kobayakawa(Shizuoka Institute of Science and Technology), M. Tada(Osaka City General Hospital), Y. Hirano(Toyohashi Municipal Hospital), Makoto Ando(National Institutes of Health), Tohru Hidaka(Yazaki (United States)), Yasumori Sobue(Japanese Red Cross Nagoya Daiichi Hospital), Masanari Kodera(Chukyo Hospital), K. Terabe(Nagoya University Hospital), H. Yasuoka, Yachiyo Kuwatsuka(Nagoya University Hospital), Masahiro Hanabayashi(Nagoya University), Noriko Miyake(Yokohama City University), Masashi Suzuki(Oita University), Kenta Misaki(Tokyo-Kita Medical Center), Takeo Kojima(Nagoya Medical Center), Takao Matsumoto(Shizuoka City Hospital), Yoko Kaneko(Keio University), K. Murata, Y. Kanayama(Toyota Kosei Hospital), T. Fujibayashi(Konan Kosei Hospital), Hiroko Hasegawa(Ministry of Internal Affairs and Communications)
Cited by 0
Related Papers
Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome
|PLoS ONE|2013|397
NAK is an IκB kinase-activating kinase
|Nature|2000|374
Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis
|Archives of Dermatology|2011|335
Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteins
|Arthritis & Rheumatism|2011|303
C5 palsy after cervical laminoplasty
|Journal of Bone and Joint Surgery - British Volume|2010|275